About Incline Therapeutics
Incline Therapeutics is a company based in Redwood City (United States) founded in 2009 was acquired by The Medicines Company in December 2012. Incline Therapeutics has raised $43.94 million across 3 funding rounds from investors including Frazier Healthcare Partners, The Medicines Company and 5AM Ventures. Incline Therapeutics operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Redwood City, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Incline Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$43.94 M (USD)
in 3 rounds
-
Latest Funding Round
$21.5 M (USD), Series B
Sep 13, 2011
-
Investors
Frazier Healthcare Partners
& 6 more
-
Employee Count
Not available
-
Acquired by
The Medicines Company
(Dec 12, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Incline Therapeutics
Incline Therapeutics has successfully raised a total of $43.94M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $21.5 million completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Incline Therapeutics
Incline Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Frazier Healthcare Partners, The Medicines Company and 5AM Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Locked | Locked | Locked | |
|
Investments are made in US life sciences and energy companies.
|
Locked | Locked | Locked |
Investor details for Incline Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Incline Therapeutics
Investment portfolio details for Incline Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Incline Therapeutics
Detailed financials for Incline Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Incline Therapeutics Comparisons
Peer comparison for Incline Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Incline Therapeutics
Incline Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| Locked | Locked | Locked |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| Locked | Locked | Locked |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| Locked | Locked | Locked |
Therapies for pain and addiction treatment are developed.
|
|
| Locked | Locked | Locked |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| Locked | Locked | Locked |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
Detailed competitors of Incline Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Incline Therapeutics
Complete news archive for Incline Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Incline Therapeutics
Incline Therapeutics was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Incline Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Incline Therapeutics is a funded company, having raised a total of $43.94M across 3 funding rounds to date.
Incline Therapeutics was founded in 2009 in Redwood City, United States, as a developer of specialty pharmaceuticals targeted at hospital settings. Operations center on iontophoretic transdermal systems for opioid analgesia in postoperative care. The lead product, IONSYS, a needleless patient-controlled device, received approvals in the US and Europe but faced voluntary recall in Europe due to stability issues and was not commercialized in the US.
Incline Therapeutics's top competitors include Flexion Therapeutics, scPharmaceuticals and Cara Therapeutics.
Incline Therapeutics has 7 investors. Key investors include Frazier Healthcare Partners, The Medicines Company, 5AM Ventures, Technology Partners, and Adams Street Partners.